Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer

Gastric cancer remains third leading cause of global cancer mortality and is the fifth most common type of cancer in the United States. A select number of gastric cancers harbor alterations in EGFR and/or have amplification/overexpression in the HER2; 2–35 and 9–38%, respectively. The advent of next...

Descripción completa

Detalles Bibliográficos
Autores principales: Adashek, Jacob J., Arroyo-Martinez, Yadis, Menta, Arjun K., Kurzrock, Razelle, Kato, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418523/
https://www.ncbi.nlm.nih.gov/pubmed/32850413
http://dx.doi.org/10.3389/fonc.2020.01312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418523/
https://www.ncbi.nlm.nih.gov/pubmed/32850413
http://dx.doi.org/10.3389/fonc.2020.01312

Ejemplares similares